Clinical Trials on Recurrent or Metastatic Breast Cancer in Korea, Republic of
Total 1408 results
-
Hope Rugo, MDJohns Hopkins University; Pfizer; Gilead Sciences; Hoosier Cancer Research Network and other collaboratorsRecruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Unresectable Breast Carcinoma | Stage IIIC Breast Cancer | Triple-Negative Breast Carcinoma | Stage III Breast CancerUnited States
-
Children's Oncology GroupCompletedRefractory or Recurrent Solid Tumors, Excluding CNS TumorsUnited States, Canada
-
Eli Lilly and CompanyActive, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial CancerUnited States, Spain, France, Belgium, Taiwan, Australia, Korea, Republic of, Japan
-
EutilexRecruitingRenal Cell Carcinoma | Non-Small Cell Lung Cancer | Solid Tumor | Prostate Cancer | Renal Cell Cancer MetastaticUnited States, Korea, Republic of
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.TerminatedTriple Negative Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Negative Breast CancerUnited States
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Singapore
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Samsung Medical CenterKorean Cancer Study Group; Health Insurance Review & Assessment ServiceUnknown
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
PfizerActive, not recruitingBreast CancerJapan, Korea, Republic of, Taiwan
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
National Cancer Institute (NCI)TerminatedExtensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompletedBreast CancerChina, India, Turkey, Korea, Republic of, Brazil, Mexico
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
TakedaRecruitingColorectal Cancer | Non-small Cell Lung Cancer (NSCLC) | Squamous Cell Cancer of Head and Neck (SCCHN)Korea, Republic of, United States, Australia
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
Georgetown UniversityRecruitingNon-metastatic Breast Cancer | Cancer Related Cognitive DeclineUnited States
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
AryoGen Pharmed Co.Completed
-
Isfahan University of Medical SciencesUnknown
-
ALX Oncology Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Advanced Cancer | NonHodgkin LymphomaKorea, Republic of, United States
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Genentech, Inc.Active, not recruitingBreast CancerUnited States, Spain, Korea, Republic of, Australia, United Kingdom
-
Hoffmann-La RocheCompletedBreast CancerChina, Korea, Republic of, Taiwan, Thailand
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal CancerSpain, Italy, Singapore, Canada, Israel, Korea, Republic of, Netherlands, Australia
-
Lycera Corp.CompletedCancerUnited States
-
Walter Reed Army Medical CenterBureau of Navy Medicine (BUMED)UnknownBreast AbnormalityUnited States
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Italy, Spain, Singapore, Belgium, Germany, Korea, Republic of, Sweden, Taiwan, France, Israel, Norway, United States
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
National Cancer Center, KoreaKorea Health Industry Development InstituteRecruitingQuality of Life | Recurrence | Gastric CancerKorea, Republic of
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Solid TumoursUnited States, Spain, Canada, Korea, Republic of
-
Galena Biopharma, Inc.CompletedBreast Cancer With Low to Intermediate HER2 ExpressionUnited States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
-
Genentech, Inc.BioNTech SEActive, not recruitingMelanoma | Head and Neck Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Renal Cancer | Other Solid CancersUnited States, Belgium, Sweden, Germany, Canada, Spain, United Kingdom, Netherlands
-
PfizerRecruitingBreast Cancer | Head and Neck CancerKorea, Republic of, Mexico, Ukraine, United States